(NASDAQ: CVAC) Curevac Nv's forecast annual revenue growth rate of -30.54% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Curevac Nv's revenue in 2025 is $594,644,444.On average, 2 Wall Street analysts forecast CVAC's revenue for 2025 to be $19,659,883,152, with the lowest CVAC revenue forecast at $12,960,021,107, and the highest CVAC revenue forecast at $26,359,745,198. On average, 2 Wall Street analysts forecast CVAC's revenue for 2026 to be $21,063,118,950, with the lowest CVAC revenue forecast at $15,519,720,619, and the highest CVAC revenue forecast at $26,606,517,280.
In 2027, CVAC is forecast to generate $53,589,922,832 in revenue, with the lowest revenue forecast at $53,589,922,832 and the highest revenue forecast at $53,589,922,832.